Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma

Analytical Biochemistry

Volumn 442, Issue 1, 2013, Pages 1-9

  Zhen, Eugene Y ^a   Higgs, Richard E ^a   Gutierrez, Jesus A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Apelin; Cation exchange; Mass spectrometry; Peptide quantification

Indexed keywords

MASS SPECTROMETRY; POSITIVE IONS;

APELIN; CATION EXCHANGES; EXTRACTION PROCESS; HEALTHY VOLUNTEERS; LOWER LIMIT OF DETECTIONS; MASS SPECTROMETRY ANALYSIS; PEPTIDE QUANTIFICATION; PHYSIOLOGICAL CONDITION;

PEPTIDES;

APELIN; PYROGLUTAMYL APELIN 13; UNCLASSIFIED DRUG; APELIN 13, PYR(1)-; ISOPROTEIN; SIGNAL PEPTIDE;

ARTICLE; BLOOD PH; CATION EXCHANGE; CONTROLLED STUDY; EXTRACTION; FEMALE; HUMAN; LIMIT OF DETECTION; MALE; MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; ADULT; AGED; BLOOD; MIDDLE AGED; REFERENCE VALUE;

ADULT; AGED; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROTEIN ISOFORMS; REFERENCE VALUES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84885572090     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2013.07.006     Document Type: Article

References (34)

1. A.Z. Kalea, D. Batlle, Apelin and ACE2 in cardiovascular disease, Curr. Opin. Invest. Drugs 11 (2010) 273-282.
2. G. Barnes, A.G. Japp, D.E. Newby, Translational promise of the apelin-APJ system, Heart 96 (2010) 1011-1016.
3. M.J. Kleinz, A.P. Davenport, Emerging roles of apelin in biology and medicine, Pharmacol. Ther. 107 (2005) 198-211. (Pubitemid 40916219)
4. D.K. Lee, V.R. Saldivia, T. Nguyen, R. Cheng, S.R. George, B.F. O'Dowd, Modification of the terminal residue of apelin-13 antagonizes its hypotensive action, Endocrinology 146 (2005) 231-236. (Pubitemid 40051744)
5. A.G. Japp, N.L. Cruden, G. Barnes, N. van Gemeren, J. Mathews, J. Adamson, N.R. Johnston, M.A. Denvir, I.L. Megson, A.D. Flapan, D.E. Newby, Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure, Circulation 121 (2010) 1818-1827.
6. A.G. Japp, N.L. Cruden, D.A. Amer, V.K. Li, E.B. Goudie, N.R. Johnston, S. Sharma, I. Neilson, D.J. Webb, I.L. Megson, A.D. Flapan, D.E. Newby, Vascular effects of apelin in vivo in man, J. Am. Coll. Cardiol. 52 (2008) 908-913.
7. I. Szokodi, P. Tavi, G. Foldes, S. Voutilainen-Myllyla, M. Ilves, H. Tokola, S. Pikkarainen, J. Piuhola, J. Rysa, M. Toth, H. Ruskoaho, Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility, Circ. Res. 91 (2002) 434-440. (Pubitemid 35034212)
8. N.P. Kadoglou, S. Lampropoulos, A. Kapelouzou, A. Gkontopoulos, E.K. Theofilogiannakos, G. Fotiadis, G. Kottas, Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease-KOZANI STUDY, Transl. Res. 155 (2010) 238-246.
9. Y. Kawamata, Y. Habata, S. Fukusumi, M. Hosoya, R. Fujii, S. Hinuma, N. Nishizawa, C. Kitada, H. Onda, O. Nishimura, M. Fujino, Molecular properties of apelin: tissue distribution and receptor binding, Biochim. Biophys. Acta 1538 (2001) 162-171. (Pubitemid 32402239)
10. K. Tatemoto, K. Takayama, M.X. Zou, I. Kumaki, W. Zhang, K. Kumano, M. Fujimiya, The novel peptide apelin lowers blood pressure via a nitric oxidedependent mechanism, Regul. Pept. 99 (2001) 87-92. (Pubitemid 32522535)
11. Y. Habata, R. Fujii, M. Hosoya, S. Fukusumi, Y. Kawamata, S. Hinuma, C. Kitada, N. Nishizawa, S. Murosaki, T. Kurokawa, H. Onda, K. Tatemoto, M. Fujino, Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum, Biochim. Biophys. Acta 1452 (1999) 25-35. (Pubitemid 29486739)
12. A.D. Medhurst, C.A. Jennings, M.J. Robbins, R.P. Davis, C. Ellis, K.Y. Winborn, K.W. Lawrie, G. Hervieu, G. Riley, J.E. Bolaky, N.C. Herrity, P. Murdock, J.G. Darker, Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin, J. Neurochem. 84 (2003) 1162-1172. (Pubitemid 36330668)
13. K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.X. Zou, Y. Kawamata, S. Fukusumi, S. Hinuma, C. Kitada, T. Kurokawa, H. Onda, M. Fujino, Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor, Biochem. Biophys. Res. Commun. 251 (1998) 471-476. (Pubitemid 28505047)
14. D.K. Lee, R. Cheng, T. Nguyen, T. Fan, A.P. Kariyawasam, Y. Liu, D.H. Osmond, S.R. George, B.F. O'Dowd, Characterization of apelin, the ligand for the APJ receptor, J. Neurochem. 74 (2000) 34-41. (Pubitemid 30012752)
15. J.J. Maguire, M.J. Kleinz, S.L. Pitkin, A.P. Davenport, [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease, Hypertension 54 (2009) 598-604.
16. M. Azizi, X. Iturrioz, A. Blanchard, S. Peyrard, N. De Mota, N. Chartrel, H. Vaudry, P. Corvol, C. Llorens-Cortes, Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli, J. Am. Soc. Nephrol. 19 (2008) 1015-1024.
17. N. De Mota, A. Reaux-Le Goazigo, S. El Messari, N. Chartrel, D. Roesch, C. Dujardin, C. Kordon, H. Vaudry, F. Moos, C. Llorens-Cortes, Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release, Proc. Natl. Acad. Sci. USA 101 (2004) 10464-10469. (Pubitemid 38924948)
18. M. Hosoya, Y. Kawamata, S. Fukusumi, R. Fujii, Y. Habata, S. Hinuma, C. Kitada, S. Honda, T. Kurokawa, H. Onda, O. Nishimura, M. Fujino, Molecular and functional characteristics of APJ: tissue distribution of mrna and interaction with the endogenous ligand apelin, J. Biol. Chem. 275 (2000) 21061-21067. (Pubitemid 30481796)
19. C. Mesmin, F. Fenaille, F. Becher, J.C. Tabet, E. Ezan, Identification and characterization of apelin peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry, J. Proteome Res. 10 (2011) 5222-5231.
20. M.X. Zou, H.Y. Liu, Y. Haraguchi, Y. Soda, K. Tatemoto, H. Hoshino, Apelin peptides block the entry of human immunodeficiency virus (HIV), FEBS Lett. 473 (2000) 15-18. (Pubitemid 30235176)
21. D.K. Lee, S.S. Ferguson, S.R. George, B.F. O'Dowd, The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with b-Arrestin, Biochem. Biophys. Res. Commun. 395 (2010) 185-189.
22. G. Foldes, F. Horkay, I. Szokodi, O. Vuolteenaho, M. Ilves, K.A. Lindstedt, M. Mayranpaa, B. Sarman, L. Seres, R. Skoumal, Z. Lako-Futo, R. De Chatel, H. Ruskoaho, M. Toth, Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure, Biochem. Biophys. Res. Commun. 308 (2003) 480-485. (Pubitemid 36945517)
23. E.Y. Zhen, M.J. Berna, Z. Jin, M.L. Pritt, D.E. Watson, B.L. Ackermann, J.E. Hale, Quantification of heart fatty acid binding protein as a biomarker for druginduced cardiac and musculoskeletal necroses, Proteomics Clin. Appl. 1 (2007) 661-671.
24. J.A. Gutierrez, J.A. Willency, M.D. Knierman, T. Coskun, P.J. Solenberg, D.R. Perkins, R.E. Higgs, J.E. Hale, From ghrelin to ghrelin's o-Acyl transferase, Methods Enzymol. 514 (2012) 129-146.
25. C. Mesmin, M. Dubois, F. Becher, F. Fenaille, E. Ezan, Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma, Rapid Commun. Mass Spectrom. 24 (2010) 2875-2884.
26. R.E. Higgs, J.P. Butler, B. Han, M.D. Knierman. Quantitative proteomics via high resolution MS quantification: capabilities and limitations, Int. J. Proteomics (in press) Art. 674282, http://dx.doi.org/10.1155/2013/674282.
27. B. DeSilva, W. Smith, R. Weiner, M. Kelley, J. Smolec, B. Lee, M. Khan, R. Tacey, H. Hill, A. Celniker, Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules, Pharm. Res. 20 (2003) 1885-1900. (Pubitemid 37449466)
28. M. Sorhede Winzell, C. Magnusson, B. Ahren, The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice, Regul. Pept. 131 (2005) 12-17. (Pubitemid 41392985)
29. C. Vickers, P. Hales, V. Kaushik, L. Dick, J. Gavin, J. Tang, K. Godbout, T. Parsons, E. Baronas, F. Hsieh, S. Acton, M. Patane, A. Nichols, P. Tummino, Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase, J. Biol. Chem. 277 (2002) 14838-14843. (Pubitemid 34952556)
30. N. De Mota, Z. Lenkei, C. Llorens-Cortes, Cloning, pharmacological characterization, and brain distribution of the rat apelin receptor, Neuroendocrinology 72 (2000) 400-407. (Pubitemid 32037653)
31. S. El Messari, X. Iturrioz, C. Fassot, N. De Mota, D. Roesch, C. Llorens-Cortes, Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure, J. Neurochem. 90 (2004) 1290-1301. (Pubitemid 39223633)
32. S.D. Katugampola, J.J. Maguire, S.R. Matthewson, A.P. Davenport, [125I]-(pyr1)apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man, Br. J. Pharmacol. 132 (2001) 1255-1260. (Pubitemid 32234709)
33. J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigne, A. Mazzucotelli, I. Castan-Laurell, I. Tack, B. Knibiehler, C. Carpene, Y. Audigier, J.S. Saulnier-Blache, P. Valet, Apelin, a newly identified adipokine up-regulated by insulin and obesity, Endocrinology 146 (2005) 1764-1771. (Pubitemid 40396885)
34. M.J. Kleinz, A.P. Davenport, Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells, Regul. Pept. 118 (2004) 119-125. (Pubitemid 38296725)